Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system

• Published in: JACC. Cardiovascular interventions Vol. 2; no. 9; pp. 828 - 833
• Main Authors: Fraccaro, Chiara, Napodano, Massimo, Tarantini, Giuseppe, Gasparetto, Valeria, Gerosa, Gino, Bianco, Roberto, Bonato, Raffaele, Pittarello, Demetrio, Isabella, Giambattista, Iliceto, Sabino, Ramondo, Angelo
• Format: Journal Article
• Language: English
• Published: United States 01.09.2009
• Subjects: Aged; Aged, 80 and over; Aortic Valve Stenosis - complications; Aortic Valve Stenosis - diagnostic imaging; Aortic Valve Stenosis - surgery; Aortography - methods; Cardiac Catheterization - adverse effects; Cardiac Catheterization - instrumentation; Feasibility Studies; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation - adverse effects; Heart Valve Prosthesis Implantation - instrumentation; Humans; Logistic Models; Male; Patient Selection; Peripheral Vascular Diseases - complications; Peripheral Vascular Diseases - diagnostic imaging; Prosthesis Design; Risk Assessment; Severity of Illness Index; Subclavian Artery - diagnostic imaging; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

Our aim was to assess the safety and feasibility of the retrograde trans-subclavian approach to transcatheter aortic valve implantation (TAVI) in selected high-risk patients with aortic stenosis (AS) and severe peripheral vasculopathy. TAVI is an emerging therapeutic option to treat inoperable/high-...